At A Glance
- This Alert Affects
- Investors who purchased Abiomed common stock.
- These investors may have legal recourse to pursue compensation for damages in light of a recent company disclosure.
- Abiomed, Inc.
- Additional Details
- Abiomed is a leading healthcare technology company which has focused itself on developing new technologies to help or replace the pumping function of the heart.
- On Nov. 1, 2012, Abiomed issued a press release announcing that the U.S. Attorney's Office for the District of Columbia was investigating the company's marketing and labeling of its Impella 2.5 heart pump system.